BRIEF-Lilly Presents First Clinical Data For Its Investigational, Next-Generation Frα

Reuters
02 Jun
BRIEF-Lilly Presents First Clinical Data For Its Investigational, Next-Generation Frα

June 2 (Reuters) - Eli Lilly and Co LLY.N:

  • LILLY PRESENTS FIRST CLINICAL DATA FOR ITS INVESTIGATIONAL, NEXT-GENERATION FRΑ TARGETING ADC IN PLATINUM-RESISTANT OVARIAN CANCER AT THE 2025 ASCO ANNUAL MEETING

  • ELI LILLY AND CO - PRELIMINARY ORR OF 55% AT 4 MG/KG DOSE

Source text: ID:nPn9s0MMPa

Further company coverage: LLY.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10